Events
Biotech and pharma companies came roaring out of the gate on the first day of the annual J.P. Morgan Healthcare Conference with big deals, expansions and promises of growth and pipeline sustainability.
In an interview with CNBC Monday, Novartis Chief Executive Officer Vas Narasimhan noted that the company is looking to become an entity that doesn’t draw its profits from treating disease, but will make money by providing cures.
Ultragenyx Pharmaceutical Inc. today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the 37TH Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 4:00 pm PT in San Francisco.
Retrophin, Inc. today announced that Stephen Aselage, chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019 at 11:00 a.m. PT (2:00 p.m. ET).
Esperion today announced that president and chief executive officer, Tim M. Mayleben, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2019 at 5:30 p.m. Pacific Time/ 8:30 p.m. Eastern Time.
Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that 2018 lived up to the “Our Best Year Yet” theme announced just one year ago, by exceeding its goals with record-breaking sales, increased employee satisfaction and retention,
The JP Morgan Healthcare Conference, being held from January 7 through 10 at the Westin St. Francis Hotel in San Francisco, is one of the premier, possible the premier, conferences for the biopharmaceutical industry.
The Ministry of Health and Prevention (MOHAP) held recently the second forum for nursing leaders to review the results achieved in the last six months after the adoption of their new strategic plan and operational nursing.
Polarean Imaging plc is pleased to announce that all the Resolutions set out in the circular dated 11 December 2018 (the “Circular”), including those necessary to implement the Fundraise to raise a total of US$4 million (£3.125 million) (before expenses), were duly passed at the General Meeting of the Company held in London earlier today.
Medtronic plc today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco.
PRESS RELEASES